Additional file 6: Figure S3.

(A) Low disease activity (LDA) and (B) disease remission (REM) defined as Simplified Disease Activity Index (SDAI) ≤11 and SDAI ≤3.3, respectively, for those patients with prior use of TNF antagonists and TNF antagonist-naive patients. Percentages of patients with (C) minimal important difference ≥0.22 on the Health Assessment Questionnaire Disability Index (HAQ DI) and (D) normal function defined as HAQ DI ≤0.5. Data are shown as observed values for all evaluable patients at each time point during long-term treatment with adalimumab (ADA). LO, last observation.

Format: PDF Size: 82KB Download file

This file can be viewed with: Adobe Acrobat Reader

Burmester et al. Arthritis Research & Therapy 2014 16:R24   doi:10.1186/ar4452